Pattern of Adverse Drug Reactions of Anticancer Drugs in Oncology Unit of a Tertiary care Teaching Hospital in South West, Nigeria

dc.contributor.authorDanbatta, A.
dc.contributor.authorMusa, A.
dc.contributor.authorAdeyemi, O.C.
dc.date.accessioned2022-01-12T13:28:21Z
dc.date.available2022-01-12T13:28:21Z
dc.date.issued2016
dc.descriptionScholarly articlesen_US
dc.description.abstractThe work was aimed at studying the pattern of ADRs due to chemotherapeutic agents with the specific objective to assess the causality, severity and management of these reactions in a tertiary care hospital, South-West Nigeria. This was a retrospective descriptive study. Medical records of patients were studied with patient details, adverse drug reactions (ADR) and medications used to manage the reactions recorded using the designed ADR data collection form. The ADRs were assessed for causality and severity using the Naranjo and Hartwig assessment scales respectively. A total of 433 ADRs were recorded from 170 patients of which 96 (56.47%) were females and 74 (43.53%) were males. The most common cancers encountered were breast (25.30%), colorectal (21.20%), cervical (10.00%) and prostate (10.00%). Nausea/vomiting (21.50%) accounted for the most ADRs followed by alopecia (17.10%). Antimetabolites (28.00%) and platinum compounds (24.00%) were the most implicated drug classes causing ADRs. Naranjo causality assessment scale showed (66.48%) of the reactions to be “possible” and (33.52%) to be “probable” while the Hartwig severity assessment scale revealed the majority of the reactions to be “moderate” (63.50%), followed by “mild” (35.11%) and “severe” (1.39%). Medications commonly prescribed for the management of the reactions were ondansetron, proton pump inhibitors, dexamethasone, chlorpheniramine and metoclopramide. The study revealed a high incidence of ADRs with chemotherapeutic agents. The prevalence of ADRs was considerably high in spite of the use of existing premedications. Most of the ADRs were found not reported using the pharmacovigilance system, leading to underreporting. As such, health caregivers should be educated to look out for such, with emphasis to employ strategies to prevent, minimize and manage ADRs of cytotoxics with peculiar side effects. The knowledge will serve to prevent similar reactions in the future by rational and judicious use of preventive measures to decrease human suffering and economic burden to the patients and society.en_US
dc.identifier.citationDanbatta A., Musa A., Adeyemi O.C. (2016). Pattern of Adverse Drug Reactions of Anticancer Drugs in Oncology Unit of a Tertiary care Teaching Hospital in South West, Nigeria. African Journal of Pharmaceutical Research and Development, 8(2): 100-107en_US
dc.identifier.urihttps://ir.unilag.edu.ng/handle/123456789/10176
dc.language.isoenen_US
dc.publisherFaculty of Pharmaceutical Sciences, University of Nigeria, Nsukka.en_US
dc.subjectAdverse drug reactionsen_US
dc.subjectChemotherapyen_US
dc.subjectCausalityen_US
dc.subjectPharmacovigilanceen_US
dc.titlePattern of Adverse Drug Reactions of Anticancer Drugs in Oncology Unit of a Tertiary care Teaching Hospital in South West, Nigeriaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Danbatta-et-al.-0802-article-5.pdf
Size:
485.31 KB
Format:
Adobe Portable Document Format
Description:
License bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: